Caribou Biosciences, Inc.CRBUNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-35.9%
5Y CAGR-36.6%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
-35.9%/yr
Annual compound
5Y CAGR
-36.6%/yr
Consistent
Percentile
P50
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202511.66%
2024-71.01%
2023148.91%
202244.31%
2021-22.35%
2020113.56%
20190.00%